{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:46:17Z","timestamp":1753875977687,"version":"3.41.2"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","award":["RVO-VFN 64165"],"award-info":[{"award-number":["RVO-VFN 64165"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Amikacin monotherapy is recommended for urinary tract infection (UTI) treatment with multi-resistant pathogens. Even though amikacin efficacy in the treatment of UTIs is dependent on its urinary concentration, there are no robust data proving that sufficiently high urinary concentration is reached in patients with reduced glomerular filtration rate (GFR).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A prospective study to monitor amikacin penetration into urine of 70 patients [40 males, median (interquartile range) age 70 (65\u201379) years] with different levels of glomerular filtration decline, including patients treated by dialysis, was conducted. The bactericidal efficacy of amikacin in urine samples has been evaluated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patients with estimated GFR (eGFR) &amp;lt;30\u00a0mL\/min had significantly lower median amikacin urinary concentration than patients with eGFR &amp;gt;30\u00a0mL\/min (89.75 vs 186.0\u00a0mg\/L, P\u00a0&amp;lt;\u00a0.0001; 200.5 vs 830.0\u00a0mg\/L, P\u00a0&amp;lt;\u00a0.0001; and 126.0 vs 408.0\u00a0mg\/L, P\u00a0&amp;lt;\u00a0.0001 for minimal, maximal and minimal together with maximal concentrations, respectively). The amount of amikacin eliminated in the first 10\u201313\u00a0h after dose administration was dependent on eGFR (r2\u00a0=\u00a00.6144, P\u00a0&amp;lt;\u00a0.0001). The urinary concentration of amikacin in patients treated by dialysis was indirectly proportional to pH of urine. The plasma concentrations of amikacin did not correlate with urinary levels in patients in either of the GFR categories. Microbiological evaluation showed that the critical urinary concentration for efficacy of amikacin during UTI monotherapy in patients treated by dialysis is 100\u00a0mg\/L. We found that 4 out of 11 patients treated by dialysis did not reach this level during the treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Systemic administration of amikacin monotherapy in patients treated by dialysis is questionable as the concentrations of amikacin in their urine are often below the threshold of effectivity. Amikacin plasma concentrations are not a major determinant of amikacin concentration in urine, therefore pulse dosing is neither necessary nor safe in patients treated by dialysis, and may cause undesirable toxicity.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfae002","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:30:58Z","timestamp":1704328258000},"source":"Crossref","is-referenced-by-count":1,"title":["Elimination and penetration of amikacin into urine in patients with decreased glomerular filtration rate"],"prefix":"10.1093","volume":"17","author":[{"given":"Jan Miroslav","family":"Hartinger","sequence":"first","affiliation":[{"name":"Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague , Prague , Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli\u0161ka","family":"Dvo\u0159\u00e1\u010dkov\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague , Prague , Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vojt\u011bch","family":"Kr\u00e1tk\u00fd","sequence":"additional","affiliation":[{"name":"Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital in Prague , Prague , Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zdenka","family":"Hru\u0161kov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital in Prague , Prague , Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Myslive\u010dek","sequence":"additional","affiliation":[{"name":"Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital in Prague , Prague , Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Bobek","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague , Prague , Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Ben\u00e1kov\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague , Prague , Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Z\u00e1vora","sequence":"additional","affiliation":[{"name":"Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague , Prague , Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Kroneislov\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague , Prague , Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbora Agatha","family":"Halouzkov\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague , Prague , Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Brejn\u00edkov\u00e1","sequence":"additional","affiliation":[{"name":"3rd Department of Surgery, First Faculty of Medicine, Charles University in Prague and Motol University Hospital , Prague , Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vendula","family":"Mart\u00ednkov\u00e1","sequence":"additional","affiliation":[{"name":"3rd Department of Surgery, First Faculty of Medicine, Charles University in Prague and Motol University Hospital , Prague , Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladim\u00edr","family":"Tesa\u0159","sequence":"additional","affiliation":[{"name":"Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital in Prague , Prague , Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ond\u0159ej","family":"Slana\u0159","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital in Prague , Prague , Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"key":"2024012218121768900_bib1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/00325481.2017.1246055","article-title":"An update on the management of urinary tract infections in the era of antimicrobial resistance","volume":"129","author":"Bader","year":"2017","journal-title":"Postgrad Med"},{"key":"2024012218121768900_bib2","doi-asserted-by":"crossref","first-page":"S312","DOI":"10.1093\/infdis\/135.Supplement_2.S312","article-title":"Clinical pharmacology of amikacin and kanamycin","volume":"134 Suppl","author":"Kirby","year":"1976","journal-title":"J Infect Dis"},{"key":"2024012218121768900_bib3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/AAC.6.4.465","article-title":"Single-dose daily gentamicin therapy in urinary tract infection","volume":"6","author":"Labovitz","year":"1974","journal-title":"Antimicrob Agents Chemother"},{"key":"2024012218121768900_bib4","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1093\/infdis\/124.Supplement_1.S98","article-title":"Pharmacology of gentamicin in man","volume":"124 Suppl","author":"Riff","year":"1971","journal-title":"J Infect Dis"},{"key":"2024012218121768900_bib5","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1128\/AAC.35.9.1849","article-title":"Use of ciprofloxacin versus use of aminoglycosides for therapy of complicated urinary tract infection: prospective, randomized clinical and pharmacokinetic study","volume":"35","author":"Fang","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"2024012218121768900_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/1120009X.2017.1376818","article-title":"Estimation of once-daily amikacin dose in critically ill adults","volume":"30","author":"Sima","year":"2018","journal-title":"J Chemother"},{"key":"2024012218121768900_bib7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/jac\/dkl489","article-title":"Combined effect of pH and concentration on the activities of gentamicin and oxacillin against Staphylococcus aureus in pharmacodynamic models of extracellular and intracellular infections","volume":"59","author":"Baudoux","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"2024012218121768900_bib8","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1128\/AAC.35.12.2617","article-title":"Impact of pH and cationic supplementation on in vitro postantibiotic effect","volume":"35","author":"Gudmundsson","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"2024012218121768900_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/infdis\/133.1.14","article-title":"Inhibition of the antibacterial activity of gentamicin by urine","volume":"133","author":"Minuth","year":"1976","journal-title":"J Infect Dis"},{"key":"2024012218121768900_bib10","first-page":"14p","article-title":"Aminoglycoside dosing and monitoring guidelines for adult patients","author":"Melinda Monteforte","year":"2015"},{"key":"2024012218121768900_bib11","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2146\/ajhp140564","article-title":"Once-daily aminoglycoside dosing: an update on current literature","volume":"72","author":"Stankowicz","year":"2015","journal-title":"Am J Health Syst Pharm"},{"key":"2024012218121768900_bib12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1159\/000523892","article-title":"Dosing of aminoglycosides in chronic kidney disease and end-stage renal disease patients treated with intermittent hemodialysis","volume":"47","author":"Halouzkov\u00e1","year":"2022","journal-title":"Kidney Blood Press Res"},{"key":"2024012218121768900_bib13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1469-0691.1998.tb00083.x","article-title":"The bactericidal activity of gatifloxacin in plasma and urine","volume":"4","author":"Wise","year":"1998","journal-title":"Clin Microbiol Infect"},{"key":"2024012218121768900_bib14","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1056\/NEJM197411282912204","article-title":"Serum versus urinary antimicrobial concentrations in cure of urinary-tract infections","volume":"291","author":"Stamey","year":"1974","journal-title":"N Engl J Med"},{"key":"2024012218121768900_bib15","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1056\/NEJM196805092781902","article-title":"Effect of renal function on urinary recovery of orally administered nitrofurantoin","volume":"278","author":"Sachs","year":"1968","journal-title":"N Engl J Med"},{"key":"2024012218121768900_bib16","first-page":"258","article-title":"Antibiotic concentrations in the urine from kidneys of unequal function","volume":"17","author":"Bailey","year":"1982","journal-title":"Clin Nephrol"},{"key":"2024012218121768900_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-196501000-00001","article-title":"The localization and treatment of urinary tract infections: the role of bactericidal urine levels as opposed to serum levels","volume":"44","author":"Stamey","year":"1965","journal-title":"Medicine (Baltimore)"},{"key":"2024012218121768900_bib18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s15010-013-0507-y","article-title":"Colistin bladder instillation, an alternative way of treating multi-resistant Acinetobacter urinary tract infection: a case series and review of literature","volume":"42","author":"Giua","year":"2014","journal-title":"Infection"},{"key":"2024012218121768900_bib19","doi-asserted-by":"crossref","first-page":"dlad040","DOI":"10.1093\/jacamr\/dlad040","article-title":"Intravesical aminoglycoside instillations as prophylaxis for recurrent urinary tract infection: patient satisfaction, long-term safety and efficacy","volume":"5","author":"Bilsen","year":"2023","journal-title":"JAC Antimicrob Resist"},{"key":"2024012218121768900_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/0972-5229.53110","article-title":"A comparative study to assess the effect of amikacin sulfate bladder wash on catheter-associated urinary tract infection in neurosurgical patients","volume":"13","author":"Zacharias","year":"2009","journal-title":"Indian J Crit Care Med"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfae002\/54974176\/sfae002.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/17\/1\/sfae002\/56324105\/sfae002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/17\/1\/sfae002\/56324105\/sfae002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T18:12:53Z","timestamp":1705947173000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfae002\/7505769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfae002","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"type":"print","value":"2048-8505"},{"type":"electronic","value":"2048-8513"}],"subject":[],"published-other":{"date-parts":[[2024,1]]},"published":{"date-parts":[[2024,1]]},"article-number":"sfae002"}}